Get intelligentvalue.com

Own it today or select a payment plan

Secured by Stripe

Premium Domain Name

intelligentvalue.com

intelligentvalue.com logo

is available for purchase

51 views
Visitors fromUSUS 54%·AUAU 32%·ININ 7%·GBGB 2%·FRFR 2%

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

VisaMastercardAmerican ExpressDiscoverDiners ClubJCBApple PayGoogle Pay

Healthpeak Properties Earnings Preview: What to Expect

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

With a market cap of $11.4 billion, Healthpeak Properties, Inc. (DOC) owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery across the United States. The company manages a diversified portfolio spanning outpatient medical, lab, and continuing care retirement community properties.

The Denver, Colorado-based company is expected to release its fiscal Q1 2026 results soon. Ahead of this event, analysts project DOC to report an FFO as Adjusted of $0.44 per share, a decline of 4.4% from $0.46 in the year-ago quarter. It has surpassed or met Wall Street's bottom-line estimates in the last four quarterly reports.

 

For fiscal 2026, analysts forecast Healthpeak Properties to report FFO as Adjusted of $1.73 per share, down nearly 6% from $1.84 in fiscal 2025. However, FFO as Adjusted is anticipated to grow 2.9% year-over-year to $1.78 per share in fiscal 2027. 

www.barchart.com

DOC stock has decreased nearly 17% over the past 52 weeks, lagging behind the broader S&P 500 Index's ($SPX) nearly 17% gain and the State Street Real Estate Select Sector SPDR ETF's (XLRE2% dip over the same time frame.

www.barchart.com

Shares of Healthpeak Properties fell 2.8% following its Q4 2025 results on Feb. 2, primarily due to weak forward guidance, with 2026 Nareit FFO projected at $1.70 per share - $1.74 per share, below its 2025 level of $1.81. Additionally, a drop in AFFO to $0.40 from $0.44 year-over-year and heavy capital recycling plans, including ~$1 billion in asset sales and uncertainty around the Janus Living IPO, added to concerns.

Analysts' consensus view on DOC stock is cautiously optimistic, with a "Moderate Buy" rating overall. Among 18 analysts covering the stock, seven suggest a "Strong Buy," two give a "Moderate Buy," and nine recommend a "Hold." The average analyst price target for Healthpeak Properties is $19.47, indicating a potential upside of 18.5% from the current levels.


On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  266.32
-2.14 (-0.80%)
AAPL  308.82
+3.83 (1.26%)
AMD  467.51
+17.92 (3.99%)
BAC  51.80
+0.31 (0.60%)
GOOG  379.38
-4.09 (-1.07%)
META  610.26
+2.88 (0.47%)
MSFT  418.57
-0.52 (-0.12%)
NVDA  215.33
-4.18 (-1.90%)
ORCL  192.08
+2.31 (1.22%)
TSLA  426.01
+8.16 (1.95%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.